#384 Updates in Chronic Kidney Disease with Dr. Joel Topf
Stay up-to-date with advances in chronic kidney disease (CKD)! Join our esteemed Chief of Nephrology at Kashlak Memorial Hospital, Dr. Joel Topf, as he leads us through the latest on SGLT2 inhibitors, finerenone, potassium binders, and treatment of CKD-associated metabolic acidosis.
Claim free CME for this episode at curbsiders.vcuhealth.org!
Episodes | Subscribe | Spotify | YouTube | Mailing List | askcurbsiders@gmail.com | Swag! | Free CME!
Show Segments
Claim free CME for this episode at curbsiders.vcuhealth.org!
Episodes | Subscribe | Spotify | YouTube | Mailing List | askcurbsiders@gmail.com | Swag! | Free CME!
Show Segments
- Intro, disclaimer, guest bio
- Case from Kashlak
- SGLT2i: when to initiate
- SGLT2i: adverse effects
- Finerenone
- Potassium binders
- Treatment of CKD-associated metabolic acidosis
- Outro
Credits
- Writer, Producer, Show Notes, Infographics, and Cover Art: Malini Gandhi
- Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP
- Reviewer: Leah Witt MD
- Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP
- Technical Production: PodPaste
- Guest: Dr. Joel Topf MD
Sponsor: Better Help
Visit betterhelp.com/curb today to get 10% off your first month.
Sponsor: Birch Living
Birch is giving 20% off all mattresses and 2 free eco-rest pillows at birchliving.com/curb.
Sponsor: PanaceaFinancial
Visit panaceafinancial.com to open a free account.
You Might Like
